Kuopio, Finland

Tomi Jarvinen

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Other. Active years: 1995-1999.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 24(Granted Patents)


Location History:

  • SF-70200 Kuopio, FI (1995)
  • Fin-70200 Kuopio, FI (1997)
  • 70200 Kuopio, FI (1999)

Company Filing History:

goldMedal3 out of 834,453 
Other
 patents

Years Active: 1995-1999

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Tomi Jarvinen

Introduction

Tomi Jarvinen is a notable inventor based in Kuopio, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating intraocular hypertension. With a total of 3 patents to his name, Jarvinen's work is recognized for its potential impact on eye health.

Latest Patents

Jarvinen's latest patents include innovative compositions and methods related to Anandamide analogs. These patents focus on the treatment of intraocular hypertension, highlighting the utility of Anandamides in ophthalmic compositions. His work encompasses methods of using these compounds, along with cyclodextrins, to effectively manage intraocular pressure.

Career Highlights

Throughout his career, Tomi Jarvinen has worked with various organizations, including Orion Corporation. His expertise in pharmaceutical sciences has allowed him to contribute to advancements in drug formulations and therapeutic methods.

Collaborations

Jarvinen has collaborated with esteemed colleagues such as Arto Olavi Urtti and David W Pate. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Tomi Jarvinen's contributions to the field of pharmaceuticals, particularly in the treatment of intraocular hypertension, demonstrate his commitment to innovation. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…